Krystal Biotech Inc (KRYS)

Cost of Revenue

$6.44M

Quarterly · Period ending: · USD

KRYS logo

KRYS Cost of Revenue

Latest reported$6.44M
KRYS Quarterly Cost of Revenue ($0.00 → $6.44M)
High-resolution chart · PNG

KRYS cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
6,437,000
6,323,000
10,917,000
5,663,000
7,165,000
5,028,000
4,949,000
6,684,000
6,009,000
2,419,000
4,378,000
223,000
0
0
0
0
0
1,014,999
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.